Results 201 to 210 of about 639,835 (244)

Risk Factors for Keratinocyte Carcinoma in Recipients of Allogeneic Hematopoietic Cell Transplants.

JAMA Dermatol, 2020
Scott JF, Brough KR, Grigoryan KV, Muzic JG, Kim GY, Conic RRZ, Hill ST, Brewer JD, Baum CL, Litzow MR, Hogan WJ, Patnaik MS, Hashmi SK, Lazarus HM, Bordeaux JS, Thompson CL, Gerstenblith MR, Lehman JS.   +17 more
europepmc   +1 more source

Association Between Topical Calcineurin Inhibitor Use and Keratinocyte Carcinoma Risk Among Adults With Atopic Dermatitis.

JAMA Dermatol, 2020
Asgari MM, Tsai AL, Avalos L, Sokil M, Quesenberry CP.   +4 more
europepmc   +1 more source

Keratinocyte Carcinoma Incidence by Race and Ethnicity in Older Adults With Medicare Coverage.

JAMA Dermatol
Navsaria LJ, Li Y, Tripathy S, Mohr CA, Hinkston CL, Margolis DJ, Wehner MR.   +6 more
europepmc   +1 more source

Health-Related Quality of Life in Solid Organ Transplant Recipients With vs Without Keratinocyte Carcinoma.

JAMA Dermatol, 2020
Frie M, Annema C, Knijff ESX, Bakker SJL, Ranchor AV, Eisenga MF, Rácz E.   +6 more
europepmc   +1 more source

A case of systemic toxicity after intralesional methotrexate for non-melanoma skin cancer in a patient with chronic kidney disease

JAAD Case Reports
Olivia Lamberg, MD, Jennifer G. Powers, MD, Nicole A. Negbenebor, MD   +2 more
doaj   +1 more source

Incidence and Risk Factors of Keratinocyte Carcinoma After First Solid Organ Transplant in Ontario, Canada.

JAMA Dermatol, 2019
Park CK, Fung K, Austin PC, Kim SJ, Singer LG, Baxter NN, Rochon PA, Chan AW.   +7 more
europepmc   +1 more source

Characteristics of State and Federal Malpractice Litigation of Medical Liability Claims for Keratinocyte Carcinoma, 1968 to 2018.

JAMA Dermatol, 2019
Tripathi R, Ezaldein HH, Rajkumar K, Bordeaux JS, Scott JF.   +4 more
europepmc   +1 more source

Objectively Measured Photoaging and Skin Cancer in Organ Transplant Recipients. [PDF]

Acta Derm Venereol
Wiegell SR, Philipsen PA, Kjær SK, Nash JF, Bjerring P, Hædersdal M.   +5 more
europepmc   +1 more source

The association of metformin use with keratinocyte carcinoma development in high-risk patients

Dermatologic Therapy, 2020
Keratinocyte carcinoma (KC) is the most common malignancy in white skinned populations. Metformin one of the most commonly prescribed drugs and has been reported to protect against solid cancers.
Mastorakos George, Alexander Stratigos
exaly   +2 more sources

Keratinocyte Carcinoma [PDF]

Ca-A Cancer Journal for Clinicians, 2003
Keratinocyte carcinoma is by far the most common cancer in the United States. Basal cell carcinomas and squamous cell carcinomas account for approximately 80% and 20% of cases of KC, respectively. The term nonmelanoma skin cancer is commonly used to refer to squamous cell carcinomas and basal cell carcinomas; however, other types of nonmelanoma skin ...
Martin Weinstock
exaly   +3 more sources